Allergan (AGN) Tops Q2 EPS by 1c
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
Allergan (NYSE: AGN) reported Q2 EPS of $3.35, $0.01 better than the analyst estimate of $3.34. Revenue for the quarter came in at $3.68 billion versus the consensus estimate of $4.1 billion.
For earnings history and earnings-related data on Allergan (AGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McDonald's (MCD) Tops Q4 EPS by 3c
- Seaport Global Securities Downgrades FMC Corp. (FMC) to Neutral
- OpenText (OTEX) Completes Acquisition of Documentum
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!